Cargando…
Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease
Congenital metabolic diseases are a group of hereditary disorders caused by the deficiency of a single specific enzyme activity. Without appropriate therapy, affected patients suffer severe neurologic disability and eventual death. The current mainstays of management attempt to slow disease progress...
Autores principales: | Takano, Chika, Grubbs, Brendan H., Ishige, Mika, Ogawa, Erika, Morioka, Ichiro, Hayakawa, Satoshi, Miki, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133340/ https://www.ncbi.nlm.nih.gov/pubmed/33547875 http://dx.doi.org/10.1002/sctm.20-0225 |
Ejemplares similares
-
Nutrient management in the intrapartum period in maternal maple syrup urine disease
por: Takano, Chika, et al.
Publicado: (2021) -
Congenital Hyperinsulinism and Maple Syrup Urine Disease: A Challenging Combination
por: Al Shidhani, Azza, et al.
Publicado: (2023) -
Neuroradiological findings in maple syrup urine disease
por: Indiran, Venkatraman, et al.
Publicado: (2013) -
Intramyelinic edema in maple syrup urine disease
por: Cornelius, Leema Pauline, et al.
Publicado: (2014) -
Maple syrup urine disease: mechanisms and management
por: Blackburn, Patrick R, et al.
Publicado: (2017)